LifeArc Ventures
About
LifeArc Ventures LifeArc Ventures is part of LifeArc, a medical research charity with a remarkable funding model. it's self-financing through royalties from Keytruda (sold to CPPIB for $1.297B in 2019), giving it a substantial permanent capital base. The strategy is to invest £1.3B by 2030, and the portfolio has expanded from 14 companies in 2022 to 20 by end- 2025, investing across therapeutics, HealthTech, and medical devices at seed and Series A stages. Recent activity demonstrates both the
Industries
Stage focus
SeedSeries A
Geography
UKEurope
Notable investments
- Maxion Therapeutics
- Tribune Therapeutics
- RQ Biotechnology
- Closed Loop Medicine
Raising from LifeArc Ventures?
I've worked with founders across the industrial stack. If LifeArc Ventures is on your list, I can help you map the introduction path, sharpen the narrative, and run a tight process.
Talk to Dan